# Atherectomy By Laser Ablation With Turbo-Elite

> **NCT02307370** · NA · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 44 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Peripheral Vascular Disease

## Interventions

- **DEVICE:** Turbo-Elite Laser Catheter

## Key facts

- **NCT ID:** NCT02307370
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-11
- **Final completion:** 2016-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307370, "Atherectomy By Laser Ablation With Turbo-Elite". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02307370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*